Hematologic malignancies: selecting rabbit ATLG dose in children

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • In children with hematological malignancies who received unrelated donor transplant chosen via high-resolution human leukocyte antigen (HLA)-typing, rabbit anti-T-lymphocyte globulin (ATLG) at 15 mg/kg deliver improved survival and non-relapse mortality (NRM) compared with at 30 mg...